<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="362408">
  <stage>Registered</stage>
  <submitdate>18/04/2012</submitdate>
  <approvaldate>23/04/2012</approvaldate>
  <actrnumber>ACTRN12612000454875</actrnumber>
  <trial_identification>
    <studytitle>Brain waves during ventilatory response tests</studytitle>
    <scientifictitle>A study in normal subjects and obstructive sleep apnea patients undergoing ventilatory response testing, to assess the effects of acute hypoxia and hypercapnia on the electroencephalogram</scientifictitle>
    <utrn>Nil</utrn>
    <trialacronym>Nil</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>obstructive sleep apnea</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Sleep apnoea</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Subjects will be tested ventilatory response to hypercapnia and hypoxia under two standard protocols: Duffins modified rebreathing protocol and Rebuck and Campbell protocol. Two channel EEG (C3-A2, C4-A1) will be recorded during the ventilatory response tests.  In detail:
Duffins rebreathing protocol involves with a ~5-minute session of ventilatory response to hypercapnia under iso-oxia and hyperoxia (PO2=150mmHg), and a 5-minute session of ventilatory response to hypercapnia under iso-oxia and hypoxia (PO2=50mmHg). There will be a 5-minute of breathing room air and a 5-minute of hyperventilation (PCO2 controlled between 19-25 mmHg) prior to each of the two rebreathing sessions. 
Rebuck and Campbell protocol tests ventilatory response to hypoxia, which involves with a ~ 5-minute session of rebreathing with a CO2 scrubber in the circuit. There is also a 5-minute of breathing room air prior to the session.
There is a half an hour resting break between the two Duffin's protocol sessions and before the Rebuck and Campbell protocol session.</interventions>
    <comparator>There is no control group.</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Other interventions</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Primary outcome of interest is the potential relationship between the change of end tidal PCO2 and the change of EEG spectral power. (End tidal PCO2 is a key parameter measured during the ventilatory response tests using a fast response CO2 analyser.)</outcome>
      <timepoint>During the ventilatory response tests, baseline breathing room air phase compared with the hypercapnic phase of the single test session</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Potential relationship between the change of PO2/SpO2 and the change of EEG spectral power. (PO2 is measured by a fast response O2 analyser during the venbtilatory response tests, and SpO2 is measured by an oxymeter using ear-clip sensor.)</outcome>
      <timepoint>During the ventilatory response tests, baseline breathing room air phase compared with the hypercapnic phase of the single test session</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Potential difference in the pattern of change of EEG spectral power between normal subjects and sleep apnea patients in responding to hypercapnia and hypoxia.</outcome>
      <timepoint>The matching ventilatory response tests sessions</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Healthy normal subjects and obstructive sleep apnea patients with apnea/hypopnea index (AHI)&gt;15.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>65</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Sleep apnea patients: waking hypoxemia (oxygen saturation &lt; 95%), BMI &gt; 38 kg/m^2, severe COPD or other lung disease, uncontrolled cardiac disease
Normal subjects: No concurrent medical complaint including sleep apnea</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Diagnosis</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures>Nil</designfeatures>
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>23/04/2012</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>24</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Dept of Respiratory and Sleep Medicine, RPA Hospital</primarysponsorname>
    <primarysponsoraddress>Missenden Rd, Camperdown, NSW 2050</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>New Staff Awards, Sydney University Medical School</fundingname>
      <fundingaddress>Edward Ford Building, Sydney Medical School, Sydney University, NSW 2006 Australia</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>NHMRC Health Professional Research Fellowship</fundingname>
      <fundingaddress>National Health and Medical Research Council
GPO Box 1421
Canberra ACT 2601</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This is a physiological study to assess potential brain waves change during the ventilatory response to hypercapnia and hypoxia tests. We hypothesize that there is an intrinsic link between the change of blood CO2 level and the spectral power of brain waves.</summary>
    <trialwebsite>Nil</trialwebsite>
    <publication>Nil</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Sydney Local Health District, Ethic Review Committee, RPAH Zone</ethicname>
      <ethicaddress>Research development office, RPAH, Missenden Rd, Camperdown, NSW 2050 Australia</ethicaddress>
      <ethicapprovaldate>8/12/2011</ethicapprovaldate>
      <hrec>X11-0325 HREC/11/RPAH/505</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr David Wang</name>
      <address>Dept of Respiratory and Sleep Medicine, RPA Hospital, Missenden Rd, Camperdown, NSW 2050.</address>
      <phone>61 2 9114 0446</phone>
      <fax>61 2 9515 7196</fax>
      <email>david.wang@sydney.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr David Wang</name>
      <address>Dept of Respiratory and Sleep Medicine, RPA Hospital, Missenden Rd, Camperdown, NSW 2050.</address>
      <phone>61 2 9114 0446</phone>
      <fax>61 2 9515 7196</fax>
      <email>david.wang@sydney.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>